Connect with us

Technology

PARAMOUNT GLOBAL’S SPECIAL COMMITTEE ANNOUNCES RECEIPT OF ACQUISITION PROPOSAL AND 15-DAY EXTENSION OF “GO SHOP” PERIOD TO CONTINUE ENGAGEMENT

Published

on

NEW YORK, Aug. 21, 2024 /PRNewswire/ — The Special Committee of the Board of Directors (the “Special Committee”) of Paramount Global (NASDAQ: PARA, PARAA) (“Paramount” or “the Company”) today announced the receipt of an acquisition proposal from Edgar Bronfman, Jr., on behalf of a consortium of investors (the “Bronfman Consortium”), that the Special Committee has determined qualifies the Bronfman Consortium as an “Excluded Party” under the terms of the Skydance transaction agreement.  As a result, the “go shop” period is extended for the Bronfman Consortium until September 5, 2024, pursuant to the transaction agreement to which the Company remains subject.

There can be no assurance this process will result in a Superior Proposal.  The Company does not intend to disclose further developments unless and until it determines such disclosure is appropriate or is otherwise required.

During the go-shop period, representatives of the Special Committee contacted more than 50 third parties to determine whether they had an interest in making a proposal to acquire Paramount.  With respect to other parties, the go-shop period will expire at 11:59 p.m. Eastern Time today.

Centerview Partners LLC serves as financial advisor to the Paramount Special Committee and Cravath, Swaine & Moore LLP serves as legal counsel.

Important Information About the Transactions and Where To Find It
In connection with the proposed transactions involving Paramount, Skydance and NAI (the “Transactions”), Paramount will file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 that will include an information statement on Schedule 14C and that will also constitute a prospectus of Paramount. Paramount may also file other documents with the SEC regarding the Transactions.

This document is not a substitute for the information statement/prospectus or registration statement or any other document that Paramount may file with the SEC. INVESTORS AND SECURITY HOLDERS OF PARAMOUNT ARE URGED TO READ THE REGISTRATION STATEMENT, WHICH WILL INCLUDE THE INFORMATION STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTIONS AND RELATED MATTERS. Investors and security holders may obtain free copies of the registration statement on Form S-4 (when available), which will include the information statement/prospectus, and other documents filed with the SEC by Paramount through the website maintained by the SEC at www.sec.gov or by contacting the investor relations department of Paramount (+1-646-824-5450; jaime.morris@paramount.com).

No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell, any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.

Cautionary Notes on Forward-Looking Statements
This communication contains both historical and forward-looking statements, including statements related to our future results, performance and achievements. All statements that are not statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Similarly, statements that describe our objectives, plans or goals are or may be forward-looking statements. These forward-looking statements reflect our current expectations concerning future results and events; generally can be identified by the use of statements that include phrases such as “believe,” “expect,” “anticipate,” “intend,” “plan,” “foresee,” “likely,” “will,” “may,” “could,” “estimate” or other similar words or phrases; and involve known and unknown risks, uncertainties and other factors that are difficult to predict and which may cause our actual results, performance or achievements to be different from any future results, performance or achievements expressed or implied by these statements.

Important risk factors that may cause such a difference include, but are not limited to: (i) that the Transactions may not be completed on anticipated terms and timing (or at all), (ii) that a condition to closing of the Transactions may not be satisfied, including the failure to receive any required regulatory approvals from any applicable governmental entities (or any conditions, limitations or restrictions placed on such approvals), (iii) that the anticipated tax treatment of the Transactions may not be obtained, (iv) the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the combined business after the consummation of the Transactions, (v) potential litigation relating to the Transactions that could be instituted against Paramount or its directors, (vi) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transactions, including the effect of the Transactions on the Company’s employees, commercial partners, clients and customers, and contractual restrictions while the Transactions are pending, (vii) any negative effects of the announcement, pendency or consummation of the Transactions on the market price of Paramount’s common stock and on Paramount’s or Skydance’s operating results, (viii) risks associated with third party contracts containing consent and/or other provisions that may be triggered by the Transactions, (ix) the risks and costs associated with the integration of, and the ability of Paramount and Skydance to integrate, the businesses successfully and to achieve anticipated synergies, (x) the risk that disruptions from the Transactions will harm Paramount’s business, including current plans and operations or by diverting management’s attention Paramount’s ongoing business operations, (xi) the ability of Paramount to retain and hire key personnel and uncertainties arising from leadership changes, (xii) legislative, regulatory and economic developments, (xiii) the other risks described in Paramount’s most recent annual report on Form 10-K and quarterly report on Form 10-Q, (xiv) that the acquisition proposal received from the Bronfman Consortium may not result in a Superior Proposal, and (xv) management’s response to any of the aforementioned factors. There may be additional risks, uncertainties and factors that we do not currently view as material or that are not necessarily known.

These risks, as well as other risks associated with the Transactions, will be more fully discussed in the information statement/prospectus that will be included in the registration statement on Form S-4 that will be filed with the SEC in connection with the Transactions. While the list of factors presented here is, and the list of factors to be presented in the registration statement on Form S-4 is, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Paramount’s consolidated financial condition, results of operations, credit rating or liquidity. The forward-looking statements included in this communication are made only as of the date of this communication, and we do not undertake any obligation to publicly update any forward-looking statements to reflect subsequent events or circumstances, except as otherwise required by applicable law.

Contact:
Brunswick Group
ParamountSpecialCommittee@brunswickgroup.com
(212) 333 – 3810

View original content:https://www.prnewswire.com/news-releases/paramount-globals-special-committee-announces-receipt-of-acquisition-proposal-and-15-day-extension-of-go-shop-period-to-continue-engagement-302228032.html

SOURCE The Special Committee of the Board of Directors of Paramount Global

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

CASIO Aims to Capture the Capital’s Fashion-Centric Urban Youth with its New Exclusive Store at Kamla Nagar

Published

on

By

NEW DELHI, Sept. 23, 2024 /PRNewswire/ — Casio Computer Co. Ltd, headquartered in Japan and the parent company of Casio India, launches its exclusive store in Kamla Nagar. With this endeavour, the brand has strengthened its retail footprint to 64 stores across India with the fifth exclusive Casio store in New Delhi.

Located in the heart of Kamla Nagar market, a vibrant hub for Delhi University students, the new Casio Exclusive store is poised to become an emblem of trendsetting timepieces, blending Japanese quality and craftsmanship with sophisticated style. The store features G-SHOCK’s Limited-Edition drops, all iconic styles of 5000, 5600, 6900, 110 & 2100 Series and the latest launches from the G-STEEL range. Customers will find timepieces that showcase precision and design—from the rugged durability of G-SHOCK to the timeless elegance of Casio watches to the sophisticated chronographs of Edifice, and the nostalgic appeal of Vintage—catering to a wide array of tastes and preferences.

Speaking about the launch, Mr. Hideki Imai, Managing Director of Casio India, said, “We are thrilled to announce the opening of our newest CASIO store in Kamla Nagar, marking our fifth milestone in Delhi and our 64th across India. This launch represents a significant step in our nationwide expansion and our commitment to engaging with the students and watch enthusiasts who frequently visit and reside in the North campus of Delhi University.

“Kamla Nagar, with its vibrant community of young, creative minds, is the ideal location for our newest store. This launch reinforces our dedication to delivering unique and immersive experiences to our consumers in Delhi NCR, aligning with their evolving lifestyles and preferences. We look forward to welcoming our customers to the new store, where they can experience a fine blend of Japanese craftsmanship, unmatched durability and trendsetting style.”

Set to open its doors to Delhi University’s fashion and watch enthusiasts who value individuality and a unique sense of style, this store promises an enthralling experience unlike any other. Located at Shop No. 33/34, Kamla Nehru Marg, Bungalow Road, the brand invites visitors to explore its newly curated space, where every corner embodies the spirit of innovation and creativity. The store is operational from 10:30 AM to 09:30 PM on all days of the week.

About Casio India Co. Pvt. Ltd.:

Casio India Co. Pvt. Ltd.(CIC) is the Indian subsidiary of Casio Computer Co., Ltd., Tokyo, Japan, one of the world’s leading manufacturers of consumer electronics and business equipment solutions. Casio India has established a dynamic presence in the Indian market since 1996, emerging as a leading and cherished consumer goods manufacturer. Casio India’s range of products includes the sales and marketing of Timepieces, Electronic Musical Instruments, Desktop Calculators, Scientific Calculators, Label Printers, and Clocks.

 Setting the benchmark for excellence, Casio India is dedicated to embodying the spirit of innovation and quality that defines the Casio legacy. With a strong commitment to its corporate creed of ‘creativity and contribution,’ Casio has consistently translated this ethos into the creation of innovative products making a positive impact on society.

For more information, visit https://www.casio.com/in/

Photo: https://mma.prnewswire.com/media/2512416/Kamla_Nagar_store.jpg

 

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/casio-aims-to-capture-the-capitals-fashion-centric-urban-youth-with-its-new-exclusive-store-at-kamla-nagar-302255299.html

Continue Reading

Technology

Hospital in Greenland chooses Sectra’s radiology solution–enhanced cross-country collaboration for improved patient care

Published

on

By

LINKÖPING, Sweden, Sept. 23, 2024 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its enterprise imaging solution to Dronning Ingrids hospital (DIH) in Greenland. The solution will enhance DIH’s ongoing collaboration with hospitals in Denmark, addressing resource and subspecialty challenges, and ultimately improving patient care in the region. 

“The partnerships we have with hospitals in Denmark are highly important to us as we, being sparsely populated, struggle to recruit staff and cover medical specialties locally. To deliver care at the speed and quality we want, we need to both increase the efficiency of our internal radiology workflows and facilitate the cooperation with healthcare providers in Denmark. Sectra’s unified platform enables this by providing easy access to images, data, patient portfolio and necessary tools, along with the ability to efficiently share information,” says Cosmus Pyndt, Manager of the diagnostic and therapeutic department in the region.

DIH is Greenland’s central hospital. It is located in the city of Nuuk, also supporting 15 clinics spread around the country. The contract for Sectra’s enterprise imaging solution was signed in the second quarter of Sectra’s 2024/2025 fiscal year following a donation to the hospital from Kirsten og Freddy Johansens Fond. DIH will initially utilize the solution’s module for radiology.

“Sharing resources, expertise and workload between hospitals within a region or, as in this case, even across borders, is crucial in handling the increasing workloads in healthcare and resource shortages. Therefore, the sharing of information and images between hospitals should be efficient and easy. It is encouraging to witness the collaboration between DIH and hospitals in Denmark. The involvement of Rigshospitalet in Denmark, which went live with Sectra this summer, and particularly the expertise of Chief Radiologist Martin Lundsgaard Hansen, has been helpful in shaping this project,” says Sune Henriksen, Managing Director, Sectra Denmark.

He continues: “I am honored to support Dronning Ingrids hospital in delivering high-quality patient care, and we are excited about this new chapter for Sectra as we extend to support healthcare in Greenland.”

Sectra’s enterprise imaging solution provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra’s website to read more about Sectra and why it’s top-ranked in ‘Best in KLAS‘.

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2023/2024 fiscal year totaled SEK 2,964 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.

For further information, please contact:
Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/hospital-in-greenland-chooses-sectra-s-radiology-solution-enhanced-cross-country-collaboration-for-i,c4040465

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/hospital-in-greenland-chooses-sectras-radiology-solutionenhanced-cross-country-collaboration-for-improved-patient-care-302255306.html

Continue Reading

Technology

FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production

Published

on

By

OXFORD, England, Sept. 23, 2024 /PRNewswire/ — FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery specialist Volta Energy Technologies, current investors (Oxford Science Enterprises and University of Oxford), Excellis Holding and angels.

Founded in 2022, FluoRok is a University of Oxford spin-out that has developed an innovative patented method to access fluorochemicals, chemicals containing the element fluorine and key to global energy transition, healthcare and food supply.

With a growing market valued at $24bn, fluorochemical manufacturing relies on a centuries-old, carbon-intensive process centred around hydrogen fluoride (HF), a highly-toxic, hazardous and difficult-to-handle chemical. FluoRok has developed a safe and sustainable approach completely bypassing HF and providing environmentally friendly access to fluorochemicals while reducing process costs. FluoRok’s groundbreaking innovation has gained substantial traction, attracting numerous potential customers across core markets of Li-ion battery electrolyte salts and agrochemicals.

The funding will support team growth and expanded production facilities for the initial supply of fluorinating reagents and lithium hexafluorophosphate (LiPF6), a key component of lithium-ion batteries.

Dr Gabriele Pupo, CEO and founder of FluoRok, said: “We are delighted to welcome BGF, Green Generation Fund and Volta Energy Technologies to our investor base. Their experience of building breakthrough businesses in battery and sustainable technologies is invaluable. With an outstanding investor syndicate, we continue our mission to make fluorochemicals production safer, cheaper, and more sustainable. This investment is critical in scaling and commercialising our proprietary technology with partners across the global fluorochemical supply chain, and in accelerating technology that will provide a reliable and localised supply of a key component of Li-ion batteries.”

Dennis Atkinson, investor at BGF, said: “FluoRok’s approach transforms the safety and sustainability of fluorochemical production while reducing costs. Particularly encouraging is significant early demand from customers worldwide and we look forward to supporting FluoRok’s journey to disrupt the global market and reach commercial scale.”

Manon Littek, founding partner at Green Generation Fund, said: “FluoRok’s revolutionary process offers a breakthrough for the fluorination industry, enabling access to compounds fundamental to energy transition, global food supply, and health. As we continue our mission toward a resilient and sustainable future, GGF is thrilled to partner with a future global leader in fluorination and supply chain independence.”

Dr Jeff Chamberlain, CEO and Founder of Volta Energy Technologies said: “Volta is enthused and eager to support FluoRok as it commercialises and scales its unique fluorinating agents. The use of FluoRok’s reagents in the battery industry promises to enable production of fluorinated electrolyte salts, like LiPF6, without the use of toxic and corrosive hydrofluoric acid. This will reduce barrier-to-entry to the electrolyte industry in Europe and North America. Beyond the battery industry, numerous applications for FluoRok reagents provide potential to have an impact in many global markets.”

Notes:
www.fluorok.com www.bgf.co.uk  www.greengenerationfund.com
www.volta.vc

Enquiries info@fluorok.com

 

SOURCE FluoRok Limited

Continue Reading

Trending